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Conclusions: Since FIF technique was simple and achieved reasonable 
dosimetric results, it is recommended for treating right breast cancer. 
Because of the highly conformal and homogenous target dose, HTis 
recommended for breast cancer patients with SCF lymph nodes 
involvement and patients with chest wall target crossed midline 
and/or with concave chest wall.Both tomotherapy techniques were 
more favourable for left breast cancer as good target dosimetry was 
maintained. The advantages of TomoDirect might outweigh its inferior 
treatment delivery efficiency and provide an alternative treatment 
strategy only for patients require maximum sparing of OARs.  
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Purpose/Objective: To compare RapidArc (RA), 3D conformal (3D-
CRT) and conventional IMRT planning for non-metastatic gastric 
cancer using dosimetric analysis. 
Materials and Methods: In a retrospective study, ten patients 
previously treated with 3D-CRT at our institution were re-planned 
using IMRT and RapidArc techniques. Site based institutional dose 
volume constraints were used to guide plan optimization, based on 
risk of normal tissue complication probability. 3D- CRT plans with 
three to five-fields were compared with IMRT plans containing up to 
nine dynamic fields and VMAT plans with two arc therapy beams. 
Target coverage was analyzed using V95, conformity and homogeneity 
indices and DVH parameters (D1, D2, D50, D98, D99). Clinical criteria 
of organs at risk (OAR) tolerance doses were based upon D33 and D66, 
but for plan comparison, further DVH metrics were assessed. 
Results:  
Median values are reported (Table 1). 
  
 All plans met OAR dose volume constraints. For clinical PTV criteria: 
V95 ≥ 95%, all RA plans(10/10), 9/10 IMRT and 8/10 3D-CRT plans met 
this constraint. PTV coverage was superior with RA. V95 values: RA 
98.84, IMRT 98.29, 3D-CRT 97.18. PTV dose conformity was 
comparable between RA and IMRT but statistically significantly 
inferior for 3D-CRT (p= 0.02). 3D-CRT plans were designed to avoid 
kidneys where possible and for each kidney provided superior 
avoidance with respect to clinical criteria (D33, D66) when compared 
to RA and IMRT. For liver, D33 and D66 were lower with RA. All 3 
techniques provide comparable small bowel sparing. Mean values for 
Monitor Units were considerably less for RA (371) and 3D-CRT (475) 
than IMRT (1639). 
Conclusions: RA provides comparable PTV conformity and OAR 
avoidance to IMRT with less MU’s which may translate to more 
favorable treatment times. 3D-CRT can provide OAR sparing superior 
to IMRT and RA but at the expense of PTV conformity. 
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Purpose/Objective: To investigate the capability of IMRT to improve 
lung and heart sparing in treatment planning for oesophageal cancer 
and subsequently the feasibility for a simultaneously integrated boost 
(SIB) for dose escalation. 
Materials and Methods: Conventional 4-field 3D conformal 
radiotherapy (3DCRT) planning was compared with four different IMRT 
planning techniques: 5 or 7 equi-angled beams, arranged as starting 
from gantry 0º (AP) or 180º (PA), for 26 patients with oesophageal 
cancer. Prescription dose to the primary tumour and involved lymph 
nodes was 28×1.8Gy = 50.4Gy, applied as a planning objective to the 
PTV: V95%PTV≥95% (and V105%PTV≤2%). PTV margins were 1.5 cm. 
Constraints for organs at risk (OAR) were V45Gy<50% for the heart, 
mean lung dose (Dmeanlung) <16Gy, and V20Gy<30% for lungs and both 
kidneys, whereas lung sparing was considered dominant over heart 
sparing. Dose distributions were compared regarding mean dose to the 
PTV (DmeanPTV), conformity index (CI) of the 95% isodose, heart and 
lung dose, as well as the total number of objective or constraint 
violations encountered for each planning technique. Subsequently, the 
most suitable IMRT technique was applied to plan an integrated boost 
to the primary tumour of an additional 28×0.4Gy = 11.2Gy, without 
compromising the original OAR constraints. PTVboost margins around 
the primary tumour were 1 cm. 
Results: Planning results are summarized in Table 1 (mean ± SD). PTV 
volume was on average 506 ± 253 cc. Boost volume (PTVboost) was on 
average 190 ± 87 cc. IMRT resulted in a significantly more conformal 
dose to the target volume than 3DCRT. Heart dose was significantly 
lower when using IMRT. Mean lung dose and V20Gylung were significantly 
lower for IMRT plans, at the expense of higher lung volumes receiving 
a low dose level (V5Gylung). Despite small differences between the four 
IMRT techniques, the 7 beam PA arrangement was considered the 
most suitable configuration. Including an integrated boost using this 
technique resulted in a small but acceptable increase in heart and 
lung dose. Mean dose to the PTV was much larger and slightly less 
conformal, whereas conformity of the boost dose to PTVboost was 
excellent. 
TABLE 1 3DCRT IMRT 5-AP 
IMRT 5-
PA 
IMRT 7-
AP 
IMRT 7-
PA 
IMRT + 
SIB 
DmeanPTV [Gy] 50.84 ± 0.36 
50.66 ± 
0.35 
50.68 ± 
0.28 
50.62 ± 
0.37 
50.62 ± 
0.29 
56.59 ± 
1.39 
CI [-] 1.41 ± 0.12 
1.08 ± 
0.05 
1.09 ± 
0.07 
1.07 ± 
0.06 
1.07 ± 
0.06 
1.16 ± 
0.06 
DmeanPTV boost [Gy] - - - - - 62.32 ± 0.37 
CIboost [-] - - - - - 1.05 ± 0.04 
# objective
violations [-] 11 3 3 4 1 - 
V45Gyheart [%] 14.6 ± 5.9 
10.8 ± 
4.8 
10.7 ± 
4.7 
10.6 ± 
4.5 
10.5 ± 
4.5 
11.6 ± 
4.8 
Dmeanlung [Gy] 12.66 ± 3.68 
11.60 ± 
3.17 
11.53 ± 
3.18 
11.24 ± 
2.91 
11.32 ± 
3.00 
12.21 ± 
3.31 
V20Gylung [%] 24.9 ± 5.8 
16.8 ± 
6.5 
14.9 ± 
6.5 
14.7 ± 
5.9 
14.5 ± 
6.7 
17.1 ± 
6.2 
V10Gylung [%] 44.5 ± 16.3 
44.9 ± 
13.9 
47.1 ± 
14.4 
45.6 ± 
11.7 
46.8 ± 
12.6 
50.4 ± 
15.2 
V5Gylung [%] 59.2 ± 19.2 
69.9 ± 
18.4 
69.5 ± 
18.9 
68.7 ± 
17.8 
68.1 ± 
17.8 
71.1 ± 
20.4 
# constraint
violations [-] 9 3 3 2 1 1 
 
Conclusions: IMRT planning with an integrated boost for oesophageal 
cancer is feasible with a relatively simple and straightforward 
technique, and is capable of producing a conformal dose distribution 
with adequate heart and lung sparing.  
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Purpose/Objective: To compare prone position (PP) with the standard 
supine position (SP) in women undergoing tangential fields WBRT after 
breast conserving surgery. 
Materials and Methods: From September 2010 we simulated selected 
patients in the two positions according to volume of breast, mobility 
of patient and tolerance of the patient in PP. In SP deep inspiration 
breath hold was performed when treating the left breast. Ipsilateral 
breast PTV, heart and ipsilateral lung were contoured and the dose 
distribution were compared using dose-volume histograms (DVH). PTV 
receiving at least 90% of the prescription dose (V90%) was assessed in 
SP and PP. Statistical significance were calculated using the paired 
Student's t-test. 
Results: 
